GlassScriptPhysician profile
Ahmad M Boota
NPI 1083715940
$5,912.87
in general payments reported to CMS, 2019-2025
37 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $168 · 2021: $741 · 2022: $1,135 · 2023: $709 · 2024: $1,569 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,161 · Travel and Lodging: $1,218 · Education: $97.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.11 |
| Travel and Lodging | $1,217.55 |
| Education | $97.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,964.56 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $841.84 | 2019-2025 | |
| Glaxosmithkline, LLC. | $523.63 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Electromed, INC. | $477.20 | 2021-2025 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $306.24 | 2019-2023 | Tezspire, Breztri |
| Philips North America LLC | $217.11 | 2019-2022 | |
| Axsome Therapeutics, INC. | $208.89 | 2022-2025 | Sunosi |
| Genzyme Corporation | $141.05 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.04 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Sunovion Pharmaceuticals INC. | $117.49 | 2019-2020 | |
| Gilead Sciences, INC. | $99.36 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $94.77 | 2022-2023 | Dupixent |
| Ani Pharmaceuticals, INC. | $88.38 | 2023 | Purified Cortrophin Gel |
| Resmed Corp | $79.52 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $54.21 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $50.97 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.13 | 2020-2022 | |
| United Therapeutics Corporation | $43.43 | 2021-2022 | |
| Harmony Biosciences LLC | $40.65 | 2022-2023 | Wakix |
| Itamar Medical INC | $37.20 | 2025 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $36.76 | 2022 | |
| Insmed, INC. | $35.38 | 2022-2023 | Arikayce |
| Idorsia Pharmaceuticals US INC | $26.53 | 2023 | Quviviq |
| Hospira, INC. | $26.40 | 2022 | |
| Grifols USA, LLC | $25.87 | 2022 | |
| Advanced Respiratory, INC | $24.05 | 2020-2021 | |
| Vapotherm INC | $20.34 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.97 | 2024 | Lifevest |
| Alexion Pharmaceuticals, INC. | $19.93 | 2022 | |
| Amgen INC. | $18.68 | 2022 | |
| Mallinckrodt Hospital Products INC. | $16.58 | 2021 | |
| Pharming Healthcare, INC. | $16.38 | 2023 | Ruconest |
| Abbvie INC. | $16.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.35 | 2019 | |
| Pfizer INC. | $13.08 | 2023 | |
| Ekos Corporation | $12.53 | 2019 | |
| Pulmonx Corporation | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Boota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.